The possible role of hepatitis A virus in the pathogenesis of atherosclerosis

J Zhu1, A A Quyyumi, J E Norman

  • 1Cardiovascular Research Institute, MedStar Research Institute, Washington Hospital Center, Washington, DC 20010, USA.

Insights

Hepatitis A virus (HAV) infection is linked to coronary artery disease (CAD). HAV-seropositive patients showed higher CAD prevalence and C-reactive protein (CRP) levels, suggesting HAV may contribute to atherosclerosis.

Area of Science:

  • Infectious Diseases
  • Cardiovascular Medicine
  • Immunology

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • The role of infectious agents, including hepatitis A virus (HAV), in the pathogenesis of atherosclerosis is under investigation.
  • Inflammation, indicated by C-reactive protein (CRP), is a key factor in CAD development.

Purpose of the Study:

  • To investigate the association between hepatitis A virus (HAV) infection and the prevalence of coronary artery disease (CAD).
  • To determine if HAV seropositivity is an independent risk factor for CAD.
  • To examine the relationship between HAV infection and C-reactive protein (CRP) levels in patients undergoing coronary angiography.

Main Methods:

  • Serum IgG antibodies to HAV and CRP levels were measured in 391 patients undergoing coronary angiography.
  • Prevalence of CAD was compared between HAV-seropositive and HAV-seronegative individuals.
  • Logistic regression analysis was used to assess HAV seropositivity as an independent predictor of CAD and elevated CRP, adjusting for traditional risk factors and other infectious agents.

Main Results:

  • 52% of patients were positive for anti-HAV IgG antibodies.
  • CAD prevalence was significantly higher in HAV-seropositive patients (74%) compared to HAV-seronegative patients (52%) (P<.0001).
  • CRP levels were significantly higher in HAV-seropositive patients (P=.013), and HAV seropositivity independently predicted both CAD and elevated CRP.

Conclusions:

  • Hepatitis A virus (HAV) infection is significantly associated with coronary artery disease (CAD).
  • HAV seropositivity is an independent predictor of CAD risk and elevated C-reactive protein (CRP) levels.
  • These findings suggest a potential causal role for HAV in the development of atherosclerosis.

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...